Company Overview
ITC Nexus Dx is a new clinical company working to improve patient care by providing the medical community with rapid and reliable information at the Point of Care (POC). Initial products include both qualitative and quantitative cardiac diagnostic assays.
Company Highlights:
- Primary focus on expansion of assay systems in the Point of Care diagnostics industry
- Multi-product revenue generating business
- Proprietary technology and content
- Highly experienced management team
- Strong investor syndicate (Bay City Capital, Kleiner Perkins Caufield & Byers, Prolog Ventures and Warburg Pincus)
- ITC Nexus Dx is privately held and based in San Diego, California